Methods of treating intraocular pressure with activators of Tie-2

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10952992
APP PUB NO 20170079959A1
SERIAL NO

15273068

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed herein are compounds effective for activation of Tie-2 and inhibition of HPTP-beta. The compounds can provide effective therapy for eye conditions associated with angiogenesis, for example, intraocular pressure, ocular hypertension, and glaucoma.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
EYEPOINT PHARMACEUTICALS INC480 PLEASANT STREET SUITE A-210 WATERTOWN MA 02472

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Peters, Kevin Gene Cincinnati, US 31 793

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Sep 23, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 23, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00